ASSESSMENT OF NARCOTIC-ANTAGONISTS IN THE TREATMENT OF OPIOID DEPENDENCE

被引:6
作者
RESNICK, RB
RESNICK, ES
WASHTON, AM
机构
关键词
D O I
10.1146/annurev.pa.20.040180.002335
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:463 / 474
页数:12
相关论文
共 50 条
[1]  
Blachly P, 1975, DEV FIELD DRUG ABUSE, P327
[2]  
Blumberg H., 1967, US Pat, Patent No. [3332950, 3,332,950]
[3]  
BRADFORD HA, 1976, NARCOTIC ANTAGONISTS, P163
[4]  
BRAHEN LS, 1974, DEV FIELD DRUG ABUSE, P769
[5]  
Braude M C, 1976, NIDA Res Monogr, P16
[6]  
Callahan E, 1976, NIDA Res Monogr, P150
[7]   CYCLAZOCINE IN A MULTI-MODALITY TREATMENT PROGRAM - COMPARATIVE RESULTS [J].
CHAPPEL, JN ;
SENAY, EC ;
JAFFE, JH .
INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1971, 6 (03) :509-&
[8]  
FREEDMAN AM, 1967, J AMER MED ASSOC, V202, P191
[9]   CLINICAL STUDIES OF CYCLAZOCINE IN TREATMENT OF NARCOTIC ADDICTION [J].
FREEDMAN, AM ;
FINK, M ;
SHAROFF, R ;
ZAKS, A .
AMERICAN JOURNAL OF PSYCHIATRY, 1968, 124 (11) :1499-&
[10]   OPIOID PEPTIDES (ENDORPHINS) IN PITUITARY AND BRAIN [J].
GOLDSTEIN, A ;
COX, BM .
PSYCHONEUROENDOCRINOLOGY, 1977, 2 (01) :11-16